Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model
Article
Published on
Journal: Drug delivery and translational research [Category] COVID19(2023년), SARS, 치료제,
Journal: Drug delivery and translational research [Category] COVID19(2023년), SARS, 치료제,
[키워드] acute respiratory syndrome
antioxidant
Antiviral
antiviral drug
Antiviral drug candidate
assays
Body weight loss
coronavirus
COVID-19
demonstrated
Efficacy
Efficacy and safety
Epidemic
fibroblast
global public health
hamsters
Health
Histopathology
human cells
human lung epithelium
IMPROVE
Inhaled
inhaler
LDH
lipid peroxidation
lung
MDA
Nanotechnology
oral swabs
other respiratory virus
pandemic
platform
Preclinical
reduce
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2-infected hamsters
silver nanoparticle
SmaRT
SNAT.
tested
virus load
virus titer
[DOI] 10.1007/s13346-022-01166-x PMC 바로가기
[DOI] 10.1007/s13346-022-01166-x PMC 바로가기